2023 Multidisciplinary Thoracic Cancers Symposium OnDemand (Videos)

2023 Multidisciplinary Thoracic Cancers Symposium is organized by American Society for Radiation Oncology (ASTRO).

Course Opens: 12/11/2023

Description:
The 2023 Multidisciplinary Thoracic Cancers Symposium features case discussions; educational sessions on multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, supportive care; and oral abstract sessions highlighting the most current, evidence-based practices. The goal of this meeting is to provide participants with updates on current clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation techniques, surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice.

Additionally, participants will be updated on the appropriate integration of these advancements in their daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention, and management of common toxicities in the context of potentially improved clinical outcomes. This educational activity focused on several of the most complex and controversial topics in the multidisciplinary management of patients with thoracic cancers to optimize incorporation of recent advances into daily practice.

Learning Objectives:
Upon Completion Of This Activity, Participants Should Be Able To Do The Following:

• Integrate locally ablative treatment modalities for appropriate patients with oligometastatic lung cancer.
• Identify the potential advantages of proton-beam radiation therapy for thoracic malignancies.
• Implement proper monitoring and intervention strategies for immune-related toxicities.
• Explain the benefit of CT screening for lung cancer.
• Discuss the relevance of molecular diagnostic testing in the management of patients with thoracic malignancies.
• Explain the role of multidisciplinary care for early-stage/locally advanced non-small cell lung cancer.

Symposium onDemand